# South Korea Continuous Glucose Monitoring System Market > South Korea Continuous Glucose Monitoring System Market Research Report By Application (Diabetes Management, Critical Care, Sports Nutrition), By Product Type (Sensor, Transmitter, Receiver, Integrated Device), By End-user (Hospitals, Homecare, Diabetes Clinics), and By Technology (Microdialysis, Spectroscopy, Electrochemical) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 11.15% - **2024:** $ 250 Million - **2025:** $ 277.88 Million - **2035:** $ 800 Million - **Key Players:** Dexcom (US), Abbott (US), Medtronic (US), Senseonics (US), Roche (CH), GlucoMe (IL), Insulet (US), B. Braun (DE) **Report ID:** MRFR/MED/48288-HCR · **Pages:** 200 · **Author:** Rahul Gotadki · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/south-korea-continuous-glucose-monitoring-system-market-50045 --- ## Market Summary ## **South Korea Continuous Glucose Monitoring System Market Overview** As per MRFR analysis, the South Korea Continuous Glucose Monitoring System Market Size was estimated at 101.76 (USD Million) in 2023.The South Korea Continuous Glucose Monitoring System Market is expected to grow from 110(USD Million) in 2024 to 280 (USD Million) by 2035. The South Korea Continuous Glucose Monitoring System Market CAGR (growth rate) is expected to be around 8.865% during the forecast period (2025 - 2035). **Key South Korea Continuous Glucose Monitoring System Market Trends Highlighted** The market for continuous glucose monitoring systems (CGMS) in South Korea is expanding significantly, driven mostly by the rising incidence of diabetes in the area. To help its population deal with this rising health issue, the South Korean government is aggressively supporting diabetes control programs. As patients look for better ways to manage their illness, there is an increasing need for real-time glucose monitoring. This has led to technological developments such as more accurate, smaller devices that continuously transmit glucose level data. The creation of more integrated systems that can easily interface with mobile applications and let users track their blood sugar levels in addition to dietary and exercise data presents prospects. These kinds of solutions promote individualised treatment regimens, which can greatly improve patient results and care. Furthermore, South Korea's healthcare system is moving more and more in the direction of preventative care, which fosters innovation in CGMS. North Korea's recent trends indicate a greater emphasis on digital health solutions and health technology. Artificial intelligence is increasingly being used into CGMS to support predictive analytics that assist users foresee glycaemic episodes. Additionally, patient education and awareness campaigns regarding the value of CGMS are becoming more and more important, which is gradually altering the nation's views on glucose monitoring. Overall, the market for continuous glucose monitoring systems in South Korea is changing due to a mix of government initiatives, technology breakthroughs, and growing consumer awareness. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review **South Korea Continuous Glucose Monitoring System Market Drivers** **Rising Diabetes Prevalence** The South Korea Continuous Glucose Monitoring System Market is significantly driven by the alarming increase in diabetes cases across the country. According to the Korea Centers for Disease Control and Prevention, approximately 6.1 million individuals aged 30 and older were diagnosed with diabetes in 2020, representing around 25.4% of the population in that age group. This escalation in diabetes prevalence fuels the demand for innovative monitoring solutions. Major organizations, like the Korean Diabetes Association, have noted the crucial role of continuous glucose monitoring systems in managing diabetes effectively, further enhancing the market growth. These systems provide real-time data that enable patients and healthcare providers to make informed treatment decisions, thereby improving patient outcomes and driving market expansion in South Korea. **Technological Advancements in Monitoring Devices** Innovations in technology are propelling the South Korea Continuous Glucose Monitoring System Market as manufacturers are developing more user-friendly and advanced devices. For instance, smart glucose monitoring devices equipped with wireless connectivity and smartphone integration are becoming commonplace, making it easier for patients to track their glucose levels. Companies such as Dexcom and Abbott have introduced advanced products that offer improved accuracy and ease of use. A recent report indicated that the South Korean market for diabetic monitoring devices has seen a shift toward advanced technological solutions, translating to a growing base of consumers who prefer these high-tech alternatives, thus stimulating market growth. **Government Initiatives and Support** Government initiatives in South Korea aimed at improving healthcare accessibility and affordability are significantly influencing the South Korea Continuous Glucose Monitoring System Market. The South Korean government has implemented policies that subsidize the cost of diabetes management devices, including continuous glucose monitors. Reports from the Ministry of Health and Welfare indicate that the ongoing reforms in healthcare financing are designed to enhance the accessibility of essential medical devices for patients with chronic conditions. This support not only alleviates the financial burden on patients but also encourages the adoption of continuous glucose monitoring solutions, ultimately driving market growth. **South Korea Continuous Glucose Monitoring System Market Segment Insights** **Continuous Glucose Monitoring System Market Application Insights** The South Korea Continuous Glucose Monitoring System Market is experiencing noteworthy growth, particularly within the Application sector, which encompasses Diabetes Management, Critical Care, and Sports Nutrition. With the increasing prevalence of diabetes in South Korea, the Diabetes Management Application represents a core aspect of market utilization. The integration of continuous glucose monitors in diabetes care facilitates real-time tracking and timely intervention, significantly improving patient outcomes and enhancing quality of life. Moreover, the Critical Care segment is vital as hospitals and healthcare institutions are increasingly adopting Continuous Glucose Monitoring technologies to ensure precise glucose monitoring in critically ill patients, which is crucial for effective treatment planning and management. This segment is seeing an uptick in demand due to the rising awareness of the importance of glucose levels in patient recovery and the growing incidence of conditions that require intensive monitoring. In addition, the Sports Nutrition segment is gaining traction as athletes and health-conscious individuals seek to optimize their performance through careful monitoring of glucose levels. This application is particularly significant as it aligns with the global trend towards personalized health and wellness, emphasizing the importance of maintaining optimal glucose levels to enhance athletic output and recovery. Overall, the various applications in the South Korea Continuous Glucose Monitoring System Market showcase a diverse range of needs and demands, reflecting broader trends toward health management and disease prevention. Market growth is driven by increasing healthcare awareness, technological advancements in monitoring devices, and the adoption of preventive health measures by both individuals and healthcare providers. The emphasis on self-management and early intervention continues to redefine the roles of these applications, placing them at the forefront of health technology advancements in South Korea. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review **Continuous Glucose Monitoring System Market Product Type Insights** The South Korea Continuous Glucose Monitoring System Market is poised for significant growth, with the Product Type segment playing a pivotal role in this paradigm. Among the essential components, sensors are crucial as they directly measure glucose levels in the body, leading to more accurate and reliable data for patients. Transmitters serve to relay this information to external devices, enhancing user experience and facilitating timely responses in diabetes management. The receiver acts as the interface for users, showcasing glucose readings and alerts, proving indispensable for real-time monitoring. Integrated devices, which combine functionality across sensors, transmitters, and receivers, are increasingly gaining traction due to their convenience and ease of use, leading to better patient adherence. This segmentation highlights the innovative strides being made in technology, with trends showing an increase in demand for advanced integrated systems and wearable devices. As the South Korean population grapples with rising diabetes rates, driven by urbanization and lifestyle changes, these product types address both the need for effective monitoring and the preference for seamless integration in daily medical care. The government has also been investing in healthcare technology innovations, further supporting the development of the Continuous Glucose Monitoring System market and its components. **Continuous Glucose Monitoring System Market****End-user****Insights** The South Korea Continuous Glucose Monitoring System Market showcases a diverse range of End-users, primarily consisting of Hospitals, Homecare, and Diabetes Clinics. Hospitals represent a significant portion of the market, as they are pivotal in the management of diabetes, providing advanced monitoring solutions to ensure patient safety and effective treatment plans. The Homecare segment is also gaining traction, driven by the increasing preference for remote patient management and the convenience of monitoring glucose levels at home, thereby enhancing patient adherence and lifestyle adjustments. Diabetes Clinics play a critical role in offering specialized care and education to patients, further emphasizing the need for accurate glucose monitoring technologies. The integration of Continuous Glucose Monitoring Systems in these settings not only facilitates real-time data collection for healthcare professionals but also empowers patients to take charge of their health, aligning with South Korea's healthcare objectives of improving chronic disease management. Moreover, the rising prevalence of diabetes in South Korea, coupled with the advancing technology in glucose monitoring systems, underscores the market's growth potential and its alignment with public health initiatives. **Continuous Glucose Monitoring System Market Technology Insights** The Technology segment of the South Korea Continuous Glucose Monitoring System Market is characterized by its innovative approaches that enhance glucose monitoring efficiency and accuracy. Microdialysis plays a crucial role by enabling the continuous sampling of interstitial fluid, which allows for real-time glucose level monitoring; this technology is particularly significant for diabetes management and research applications. Spectroscopy, on the other hand, leverages light absorption properties to provide non-invasive glucose measurement, catering to a growing demand for user-friendly solutions in daily health management. Additionally, Electrochemical methods dominate the segment due to their reliability and sensitivity in detecting glucose levels, making them a widely adopted choice in devices. The evolution of these technologies is driven by rising diabetes prevalence and the need for efficient blood sugar management in South Korea, where an aging population is increasingly focused on health optimization. The continuous advancements in these technologies present opportunities for higher accuracy, ease of use, and patient compliance, supporting the overall growth of the Continuous Glucose Monitoring System Market in the region. Thus, each of these technologies contributes significantly to enhancing glucose monitoring capabilities, addressing both current and emerging healthcare needs. **South Korea Continuous Glucose Monitoring System Market Key Players and Competitive Insights** The South Korea Continuous Glucose Monitoring System Market is experiencing a notable transformation driven by advancements in technology and an increasing prevalence of diabetes among the population. The market is characterized by a strong competition among various players, who are striving to enhance their product offerings and improve patient compliance through innovative solutions. Companies are investing in research and development to provide more accurate, reliable, and user-friendly devices, which allow for real-time monitoring and help manage blood glucose levels effectively. As awareness of diabetes management grows, the market is anticipated to see sustained growth, with companies competing aggressively to establish their presence and expand their market share within South Korea. Terumo Corporation has established a significant foothold in the South Korean Continuous Glucose Monitoring System Market. The company is known for its robust product lineup that includes advanced glucose monitoring devices designed to cater to the specific needs of diabetes patients. Terumo Corporation focuses on delivering high-quality products that emphasize accuracy and ease of use, which resonate well with both healthcare professionals and patients. The company's strong research and development capabilities allow it to stay ahead of the curve in terms of innovation. Its strategic approach to partnerships and collaborations with local healthcare providers further enhances its market presence, solidifying its reputation as a trusted brand in the medical technology sector within South Korea. A. Menarini Diagnostics is also a prominent player in the South Korean Continuous Glucose Monitoring System Market, offering a comprehensive range of products and services aimed at improving glucose monitoring solutions for diabetes management. The company is recognized for its cutting-edge technology and user-centered designs. A. Menarini Diagnostics has successfully developed key products that provide accurate glucose readings, enabling patients to manage their condition more effectively. The company's strong market presence is backed by its focus on high-quality standards and continuous improvement initiatives. A. Menarini Diagnostics has engaged in strategic mergers and acquisitions to further bolster its position in the South Korean market, allowing it to expand its product portfolio and enhance its competitive edge. With its commitment to innovation and patient care, A. Menarini Diagnostics is well-positioned to capitalize on the growth opportunities in the South Korean Continuous Glucose Monitoring System Market. **Key Companies in the South Korea Continuous Glucose Monitoring System Market Include:** - Terumo Corporation - A. Menarini Diagnostics - Medtronic - Dexcom - Ascensia Diabetes Care - Senseonics - Boehringer Ingelheim - Novo Nordisk - Ypsomed - GlucoMe - Roche - Insulet Corporation - Abbott **South Korea Continuous Glucose Monitoring System****Market****Developments** The South Korea Continuous Glucose Monitoring System Market has experienced significant developments lately, particularly with advancements in technology and growing demand for diabetes management solutions. Recent news highlights the launch of new CGM devices by companies like Dexcom and Abbott aimed at enhancing patient experience and accuracy in glucose monitoring. Medtronic has also introduced an innovative system designed to improve insulin delivery, reflecting the trend towards integrated diabetes care. In the domain of mergers and acquisitions, Terumo Corporation announced a strategic acquisition in August 2023, focused on expanding its market share in the CGM sector. Meanwhile, growth in market valuation is evident, with companies like Ypsomed and Roche adapting their product lines to meet increasing consumer demand, attracting investor interest. This surge in the market is further bolstered by the South Korean government’s initiatives to promote advanced healthcare technologies and enhance diabetes management, aiming for improved health outcomes among its population. Over the past few years, notable changes have included an uptick in Research and Development expenditures by key players in the sector, driving innovation and competition within the market landscape. **South Korea Continuous Glucose Monitoring System Market Segmentation Insights** **Continuous Glucose Monitoring System Market Application Outlook** - Diabetes Management - Critical Care - Sports Nutrition **Continuous Glucose Monitoring System Market Product Type Outlook** - Sensor - Transmitter - Receiver - Integrated Device **Continuous Glucose Monitoring System Market End-userOutlook** - Hospitals - Homecare - Diabetes Clinics **Continuous Glucose Monitoring System Market Technology Outlook** - Microdialysis - Spectroscopy - Electrochemical ## Market Drivers ### Rising Diabetes Prevalence The continuous glucose-monitoring-system market is experiencing growth due to the increasing prevalence of diabetes in South Korea. Recent statistics indicate that approximately 13.4% of the adult population is affected by diabetes, leading to a heightened demand for effective management solutions. This trend is further exacerbated by an aging population, as older adults are more susceptible to developing diabetes. Consequently, healthcare providers and patients are increasingly turning to continuous glucose monitoring systems as a means to enhance glycemic control and reduce the risk of complications. The market is projected to expand as more individuals seek innovative technologies to manage their condition effectively. ### Government Initiatives and Support Government initiatives aimed at improving diabetes care are significantly influencing the continuous glucose-monitoring-system market. In South Korea, the government has implemented various policies to promote the adoption of advanced medical technologies, including subsidies for diabetes management tools. These initiatives are designed to alleviate the financial burden on patients and encourage the use of continuous glucose monitoring systems. As a result, the market is likely to witness increased penetration of these devices, particularly among low-income populations. The government's commitment to enhancing healthcare access and quality is expected to drive market growth in the coming years. ### Technological Innovations in Devices Technological innovations are playing a crucial role in shaping the continuous glucose-monitoring-system market. Recent advancements in sensor technology, data analytics, and mobile applications have led to the development of more accurate and user-friendly devices. For instance, the introduction of real-time glucose monitoring systems with integrated smartphone applications has made it easier for users to track their glucose levels and receive alerts. This trend is likely to attract a broader consumer base, including younger individuals who are tech-savvy and prefer digital solutions for health management. As these innovations continue to evolve, the market is expected to expand further. ### Increased Focus on Preventive Healthcare The continuous glucose-monitoring-system market is also influenced by the rising focus on preventive healthcare in South Korea. As healthcare systems shift towards proactive management of chronic diseases, there is a growing recognition of the importance of early detection and intervention in diabetes care. Continuous glucose monitoring systems enable patients to monitor their glucose levels consistently, facilitating timely adjustments to their diet and lifestyle. This preventive approach not only helps in managing diabetes but also reduces the overall healthcare costs associated with diabetes-related complications. The market is expected to grow as more individuals adopt preventive measures to maintain their health. ### Growing Demand for Personalized Healthcare The continuous glucose-monitoring-system market is benefiting from the growing demand for personalized healthcare solutions. Patients are increasingly seeking tailored approaches to diabetes management that consider their unique lifestyles and health conditions. Continuous glucose monitoring systems offer real-time data that can be customized to individual needs, allowing for more effective treatment plans. This shift towards personalized healthcare is supported by healthcare professionals who recognize the importance of individualized care in improving patient outcomes. As awareness of personalized medicine grows, the market is likely to see a surge in demand for continuous glucose monitoring systems. ## Future Outlook The [Continuous Glucose Monitoring System Market](https://www.marketresearchfuture.com/reports/continuous-glucose-monitoring-system-market-20310) is projected to grow at 11.15% CAGR from 2025 to 2035, driven by technological advancements, increasing diabetes prevalence, and rising health awareness. **New opportunities:** - Development of integrated mobile health applications for real-time data analysis. - Expansion of subscription-based models for continuous monitoring services. - Partnerships with healthcare providers for bundled service offerings. By 2035, the market is expected to achieve substantial growth, positioning itself as a leader in diabetes management solutions. ## Segment Insights ### By Application: Diabetes Management (Largest) vs. Sports Nutrition (Fastest-Growing) In the South Korea continuous glucose-monitoring-system market, Diabetes Management holds the largest market share, significantly outweighing the other segments. This segment has become a primary focus for consumers and healthcare providers alike, driven by the increasing prevalence of diabetes and the necessity for effective management solutions. Each year, a greater number of individuals are adopting continuous glucose monitoring systems to maintain optimal health and blood sugar levels. On the other hand, Sports Nutrition is the fastest-growing segment in this market. The rising awareness about health and fitness, coupled with more athletes and fitness enthusiasts seeking to optimize their performance through precise glucose monitoring, has spurred this growth. Additionally, the increasing acceptance of CGMs in various sports applications is contributing to the expanding market, further indicating a diversified consumer base with varying needs. Diabetes Management: Dominant vs. Sports Nutrition: Emerging In the South Korea continuous glucose-monitoring-system market, Diabetes Management is the dominant segment, characterized by its established consumer base and extensive use in healthcare settings. Its dominance is a product of the growing diabetic population and the corresponding demand for coherent blood sugar management solutions. Conversely, Sports Nutrition is emerging as a significant player within the market, appealing to fitness enthusiasts and athletes seeking enhancements in their training and performance. This segment is gaining traction due to innovative technologies and products specifically designed to support active lifestyles. The trend highlights a shift towards personalized health management, making Sports Nutrition a critical area for future growth. ### By Product Type: Sensor (Largest) vs. Integrated Device (Fastest-Growing) Within the South Korea continuous glucose-monitoring-system market, the sensor segment holds the largest share, representing a significant portion of the overall market distribution. Following closely are the transmitter and receiver segments, which together contribute to a competitive landscape. The integrated device segment, while smaller, is rapidly gaining traction due to evolving consumer preferences for comprehensive solutions that combine monitoring and management capabilities. The growth trends in this segment are influenced by technological advancements and an increasing prevalence of diabetes in the region. As more individuals seek efficient and user-friendly monitoring systems, integrated devices are becoming the fastest-growing category, driven by innovation and a focus on patient-centric solutions. This reflects a shift towards holistic health management, with devices designed to deliver real-time data and enhance patient engagement. Sensor (Dominant) vs. Integrated Device (Emerging) The sensor segment is a dominant force in the South Korea continuous glucose-monitoring-system market, characterized by its widespread adoption owing to accuracy and reliability. Sensors are essential components, providing real-time blood glucose readings that are critical for effective diabetes management. Meanwhile, the integrated device segment is emerging rapidly, appealing to consumers looking for all-in-one solutions that integrate multiple functionalities such as glucose monitoring, alert systems, and data management into a single device. These integrated devices leverage advancements in connectivity and data analytics, thus presenting an attractive option for tech-savvy patients seeking improved control over their health. Both segments highlight a trend towards enhanced functionality and user experience, making them crucial for stakeholders in the market. ### By End User: Hospitals (Largest) vs. Homecare (Fastest-Growing) In the South Korea continuous glucose-monitoring-system market, hospitals represent the largest segment, holding a significant share of market utilization. Hospitals invest heavily in advanced glucose monitoring technologies for patient care, leading to a stable demand for these devices. The homecare segment has emerged rapidly, driven by the increasing prevalence of diabetes and the demand for convenient self-monitoring solutions. Homecare is gaining traction as more patients prefer to manage their conditions independently. The growth trends in the South Korea continuous glucose-monitoring-system market are primarily fueled by technological advancements and rising health awareness among the population. Hospitals continue to prioritize glucose monitoring in diagnostics and treatment plans, whereas homecare solutions are gaining popularity due to their ease of use, portability, and cost-effectiveness. Diabetes clinics are also making strides, but the homecare segment's rapid growth indicates a shift towards empowering patients with more control over their health management. Hospitals (Dominant) vs. Homecare (Emerging) Hospitals remain the dominant force in the South Korea continuous glucose-monitoring-system market due to their extensive resources and the critical nature of diabetes management in clinical settings. They provide comprehensive care, integrating glucose monitoring systems into patient monitoring processes. On the other hand, the homecare segment is emerging rapidly, catering to a growing number of diabetes patients who prefer the convenience of monitoring their glucose levels from home. This segment is characterized by user-friendly devices that allow patients to track their health metrics without the need for frequent hospital visits, benefiting from technological innovations that enhance their usability. ### By Technology: Electrochemical (Largest) vs. Microdialysis (Fastest-Growing) In the South Korea continuous glucose-monitoring-system market, the technology segment is predominantly led by electrochemical methods, which hold a significant market share due to their accuracy and reliability in glucose level measurements. This segment accounts for a considerable portion of total market revenues, driven by the increasing demand for efficient glucose monitoring solutions among diabetic patients. Microdialysis, although smaller in market share, is gaining traction as it offers innovative approaches for glucose monitoring, appealing to a niche market segment. Growth trends indicate a robust upward trajectory for microdialysis technology, which is projected to outpace traditional methods in the coming years. Factors contributing to this growth include advancements in miniaturization and sensor technologies, along with an increasing focus on patient comfort and flexibility in glucose monitoring solutions. As healthcare continues to evolve towards personalized medicine, microdialysis is positioning itself as an emerging contender in the market. Technology: Electrochemical (Dominant) vs. Microdialysis (Emerging) Electrochemical technology dominates the South Korea continuous glucose-monitoring-system market, characterized by its accuracy, faster response times, and relatively lower costs compared to other methods. Its established presence and widespread acceptance among patients and healthcare professionals cement its position as the leading choice for glucose monitoring. In contrast, microdialysis is an emerging technology that takes a different approach, offering potential advantages in continuous monitoring with minimal invasiveness. As it garners interest for its innovative techniques and applications in personalized diabetes management, microdialysis is set to attract investment and research, thus expanding its foothold within the market. ## Competitive Benchmarking The continuous glucose-monitoring-system market in South Korea is characterized by a dynamic competitive landscape, driven by technological advancements and increasing demand for diabetes management solutions. Major players such as Dexcom (US), Abbott (US), and Medtronic (US) are at the forefront, each employing distinct strategies to enhance their market presence. Dexcom (US) focuses on innovation, particularly with its latest CGM technology that offers real-time glucose monitoring and integration with digital health platforms. Abbott (US), on the other hand, emphasizes accessibility and affordability, aiming to expand its user base through cost-effective solutions. Medtronic (US) is leveraging its extensive experience in diabetes care to integrate CGM systems with insulin delivery devices, thereby enhancing patient outcomes and operational efficiency.The business tactics employed by these companies reflect a concerted effort to optimize supply chains and localize manufacturing processes. The market structure appears moderately fragmented, with a mix of established players and emerging startups. This fragmentation allows for diverse product offerings and fosters competition, compelling companies to innovate continuously. The collective influence of these key players shapes the market dynamics, as they vie for leadership through strategic partnerships and technological advancements. In October Abbott (US) announced a partnership with a leading telehealth provider to enhance remote patient monitoring capabilities. This strategic move is significant as it aligns with the growing trend of digital health solutions, enabling patients to manage their diabetes more effectively from home. By integrating CGM data with telehealth services, Abbott (US) positions itself as a comprehensive solution provider in diabetes management, potentially increasing patient engagement and adherence to treatment plans. In September Dexcom (US) launched its latest CGM device, which features advanced algorithms for predictive analytics. This innovation is crucial as it not only improves the accuracy of glucose readings but also empowers users with actionable insights to prevent hypoglycemic events. The introduction of this technology underscores Dexcom's commitment to enhancing user experience and solidifying its competitive edge in the market. In August Medtronic (US) expanded its product line by introducing a new CGM system that integrates seamlessly with its insulin pumps. This integration is strategically important as it offers a holistic approach to diabetes management, allowing for automated insulin delivery based on real-time glucose levels. Such advancements are likely to attract a broader customer base, particularly among patients seeking comprehensive solutions for diabetes care. As of November the competitive trends in the continuous glucose-monitoring-system market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence. Strategic alliances are becoming more prevalent, as companies recognize the value of collaboration in enhancing product offerings and expanding market reach. Looking ahead, competitive differentiation is expected to evolve, shifting from price-based competition to a focus on innovation, technological advancements, and supply chain reliability. This transition may lead to a more sustainable and patient-centric approach in the continuous glucose-monitoring-system market. ## Recent News & Developments The South Korea Continuous Glucose Monitoring System Market has experienced significant developments lately, particularly with advancements in technology and growing demand for diabetes management solutions. Recent news highlights the launch of new CGM devices by companies like Dexcom and Abbott aimed at enhancing patient experience and accuracy in glucose monitoring. Medtronic has also introduced an innovative system designed to improve insulin delivery, reflecting the trend towards integrated diabetes care. In the domain of mergers and acquisitions, Terumo Corporation announced a strategic acquisition in August 2023, focused on expanding its market share in the CGM sector. Meanwhile, growth in market valuation is evident, with companies like Ypsomed and Roche adapting their product lines to meet increasing consumer demand, attracting investor interest. This surge in the market is further bolstered by the South Korean government’s initiatives to promote advanced healthcare technologies and enhance diabetes management, aiming for improved health outcomes among its population. Over the past few years, notable changes have included an uptick in Research and Development expenditures by key players in the sector, driving innovation and competition within the market landscape. ## Report Scope | MARKET SIZE 2024 | 250.0(USD Million) | | --- | --- | | MARKET SIZE 2025 | 277.88(USD Million) | | MARKET SIZE 2035 | 800.0(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 11.15% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Dexcom (US), Abbott (US), Medtronic (US), Senseonics (US), Roche (CH), GlucoMe (IL), Insulet (US), B. Braun (DE) | | Segments Covered | Application, Product Type, End User, Technology | | Key Market Opportunities | Integration of advanced data analytics in continuous glucose-monitoring-system market enhances personalized diabetes management solutions. | | Key Market Dynamics | Rising demand for advanced continuous glucose-monitoring systems driven by technological innovations and regulatory support in South Korea. | | Countries Covered | South Korea | ## Frequently Asked Questions **Q: What was the market valuation of the continuous glucose-monitoring system in 2024?** A: The market valuation was $250.0 Million in 2024. **Q: What is the projected market valuation for 2035?** A: The projected market valuation for 2035 is $800.0 Million. **Q: What is the expected CAGR for the market during the forecast period 2025 - 2035?** A: The expected CAGR for the market during the forecast period 2025 - 2035 is 11.15%. **Q: Which application segment had the highest valuation in 2024?** A: The Diabetes Management application segment had the highest valuation at $480.0 Million in 2024. **Q: What are the key product types in the continuous glucose-monitoring system market?** A: Key product types include Sensor, Transmitter, Receiver, and Integrated Device. **Q: Which end user segment is projected to dominate the market by 2035?** A: The Homecare end user segment is projected to dominate the market by 2035. **Q: What technology segment is expected to show significant growth during the forecast period?** A: The Electrochemical technology segment is expected to show significant growth during the forecast period. **Q: Who are the leading players in the continuous glucose-monitoring system market?** A: Leading players include Dexcom, Abbott, Medtronic, and Roche. **Q: What was the valuation of the Critical Care application segment in 2024?** A: The valuation of the Critical Care application segment was $240.0 Million in 2024. **Q: How does the projected growth of the market reflect on the demand for continuous glucose-monitoring systems?** A: The projected growth indicates a rising demand for continuous glucose-monitoring systems, particularly in diabetes management. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/south-korea-continuous-glucose-monitoring-system-market-50045*